46 results
CORRESP
SPRC
SciSparc Ltd
5 Jan 24
Correspondence with SEC
12:00am
for consideration received or receivable if it expects to refund some or all of the consideration to the customer. At the end of each reporting period … of return asset and corresponding adjustment to cost of sales is also recognized for the right to recover the goods from the customer.
In certain
6-K
EX-99.3
SPRC
SciSparc Ltd
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
, files, customer lists, customer purchasing histories, price lists, distribution lists, supplier lists, production data, quality control records … and procedures, customer complaints and inquiry files, raw material lists, research and development files, records and data (including all correspondence
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
of the consideration to the customer. At the end of each reporting period, the Company updates its estimates of expected product returns and adjusts the refund … for the right to recover the goods from the customer.
In certain contracts, the Company evaluates the nature of its promise to the customer and determines
6-K
EX-99.1
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
, in accordance with customer traffic and in accordance with the directives of the Home Front Command. As for the signature date of the financial … to the customer. The price of the transaction equals the expected consideration amount as per the contract terms, deducted of any amounts collected in favor
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
and there was no customers’ traffic. As of November 2023, the Company’s branches began to open in a partial format, in accordance with customer traffic and in accordance … are recognized in profit or loss upon the transition of control over the asset or the service to the customer. The price of the transaction equals
6-K
EX-10.3
cd75bbka ki
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
F-1
s1x40e0p
27 Feb 24
Registration statement (foreign)
4:15pm
20-F
EX-4.12
4smwgzf0n4n
1 May 17
Annual report (foreign)
12:00am
6-K
EX-99.2
8qfyyu551 7gctr4i
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
424B3
jjuwpmdk 1y
13 Oct 20
Prospectus supplement
9:42am
424B3
d44ak zjhrd5
3 Feb 21
Prospectus supplement
12:10pm
424B3
f1p47l2lu u6i6f
9 Aug 21
Prospectus supplement
12:00am
F-6 POS
EX-1
wrr0ludpbzrg5sgw
26 Jul 21
Automatic registration for ADRs (post-effective amendment, foreign)
10:38am
POS AM
63n2dlxga5doxqhkw
2 May 24
Prospectus update (post-effective amendment)
5:17pm
F-3/A
EX-4.2
ezc7j0
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
F-3/A
jvzk1df
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
6-K
EX-10.1
seqzlhzh in
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
ijwp2vdl 4f9
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm